ICH M Guidelines: CTD/eCTD Structure and Global Requirements
Complete guide to the ICH M Guidelines: CTD, eCTD, stability, bioequivalence and global submissions. Ideal for RA, QA and CMC.
Read the article →Save 10% before you check out
Apply code AUGUST10 by 31 August 2026. The discount will be shown at checkout.
Apply AUGUST10One use per customer · Cannot be combined
GXP ACADEMY · ICH GUIDELINES
Practical analysis of the ICH Q, E, M and S families: pharmaceutical development, quality and risk, impurities, stability, CTD/eCTD dossiers, clinical trials and lifecycle management. Built to clarify what each guideline requires, how it connects to others and what evidence is needed in practice.
ICH Q · E · M · S
Quality, risk, impurities, regulatory dossiers and clinical trials explained through connections, operational criteria and expected evidence.
Complete guide to the ICH M Guidelines: CTD, eCTD, stability, bioequivalence and global submissions. Ideal for RA, QA and CMC.
Read the article →
Elemental and mutagenic impurities: what EMA/FDA inspectors look for — and how to keep your dossier audit-ready.
Read the article →
Implementing Q8, Q9, Q10, and Q12: Operating method, checklist, and pitfalls to avoid.
Read the article →
Prepare for EMA/FDA inspections: correctly apply the ICH E Guidelines on sponsor oversight, TMF, data integrity and risk management. Guide for QA/QP.
Read the article →
Practical ICH M7 Guide: identification, classification, TTC limits, and control strategies. For QA, QC, and RA.
Read the article →
Understanding Q8, Q9, Q10, and Q12: The global framework that guides quality, risk, and lifecycle management.
Read the article →